Cryptic SARS-CoV2-spike-with-sugar interactions revealed by ‘universal-STA’

Cryptic SARS-CoV2-spike-with-sugar interactions revealed by ‘universal-STA’

Raw STD NMR data for mixtures of ligands and a variety of proteins, including the SARS-CoV-2 spike protein. Data specific information is included in the README.txt file.

Bibliographic Details
Main Author:	Buchanan, C
Format:	Dataset
Published:	University of Oxford 2022

Similar Items

Cryptic SARS-CoV2-spike-with-sugar interactions revealed by ‘universal-STD’
by: Buchanan, C
Published: (2020)

The architecture of inactivated SARS-CoV-2 with postfusion spikes revealed by cryo-EM and cryo-ET
by: Liu, C, et al.
Published: (2020)

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
by: Huo, J, et al.
Published: (2020)

Janus Emulsion Biosensors for Anti-SARS-CoV-2 Spike Antibody
by: Li, Jie, et al.
Published: (2022)

Human basigin (CD147) does not directly interact with SARS-CoV-2 spike glycoprotein
by: Ragotte, R, et al.
Published: (2021)

Human basigin (CD147) does not directly interact with SARS-CoV-2 spike glycoprotein
by: Ragotte, RJ, et al.
Published: (2021)

SARS-CoV-2 Infection−Of Music and Mechanics of Its Spikes ! A Perspective
by: Kolel-Veetil, Manoj K, et al.
Published: (2023)

Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
by: Pomplun, Sebastian Johannes
Published: (2021)

Screening, expression, and identification of nanobody against SARS-CoV-2 spike protein
by: Su, Qianling, et al.
Published: (2023)

The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking
by: Asor, R, et al.
Published: (2022)

The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking
by: Asor, R, et al.
Published: (2022)

Interaction of SARS-CoV spike protein with lipid rafts of host cells during viral entry
by: Lu, Yanning
Published: (2008)

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
by: Wei, J, et al.
Published: (2021)

Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control
by: Liu, G
Published: (2023)

The evolution of SARS-CoV-2
by: Markov, PV, et al.
Published: (2023)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
by: Kim, KS, et al.
Published: (2021)

Does SARS-CoV-2 bind to human ACE2 stronger than SARS-CoV?
by: Nguyen, HL, et al.
Published: (2020)

Assessing antigen structural integrity through glycosylation analysis of the SARS-CoV-2 viral spike
by: Brun, J, et al.
Published: (2021)

De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
by: Pomplun, Sebastian Johannes, et al.
Published: (2021)

Technical Data of In Silico Analysis of the Interaction of Dietary Flavonoid Compounds against Spike-Glycoprotein and Proteases of SARS-CoV-2
by: Nurbella Sofiana Altu, et al.
Published: (2022)

An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
by: Chian Ho, et al.
Published: (2023)

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
by: Ejemel, M, et al.
Published: (2020)

Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein
by: Zhang, Si Min, et al.
Published: (2020)

The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)

Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
by: Van Egeren, Debra, et al.
Published: (2021)

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
by: Teng, I-Ting, et al.
Published: (2022)

Analysis of surface expressed recombinant SARS-CoV-2 spike protein using human monoclonal antibodies
by: Wu, Yanjun
Published: (2024)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2021)

Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
by: Mandolesi, M, et al.
Published: (2024)

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
by: Souza, WM, et al.
Published: (2021)

Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
by: Deng, X, et al.
Published: (2020)

Social determinants of ethnic disparities in SARS-CoV-2 infection: UK Biobank SARS-CoV-2 Serology Study
by: Omiyale, W, et al.
Published: (2023)

Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
by: Parker, R, et al.
Published: (2021)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Siti Naqiah Amrun, et al.
Published: (2020)

Gold nanorod assisted enhanced plasmonic detection scheme of COVID-19 SARS-CoV-2 spike protein
by: Das, Chandreyee Manas, et al.
Published: (2021)

Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)

Lateral flow immunoassays for SARS-CoV-2
by: Ang, Geik Yong, et al.
Published: (2022)

Serological Markers of SARS-CoV-2 Reinfection
by: Lauffenburger, Douglas
Published: (2023)

SARS-CoV-2-specific ELISA development
by: Roy, Vicky, et al.
Published: (2021)

Getting to the (germinal) centre of SARS-CoV-2
by: Richter, FC, et al.
Published: (2020)